160 related articles for article (PubMed ID: 30885360)
21. A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors.
Jia Y; Tian Q; Yang K; Liu Y; Liu Y
Biomed Res Int; 2021; 2021():5862941. PubMed ID: 34845438
[TBL] [Abstract][Full Text] [Related]
22. Conservation of immune gene signatures in solid tumors and prognostic implications.
Chifman J; Pullikuth A; Chou JW; Bedognetti D; Miller LD
BMC Cancer; 2016 Nov; 16(1):911. PubMed ID: 27871313
[TBL] [Abstract][Full Text] [Related]
23. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.
Hao Y; Li D; Xu Y; Ouyang J; Wang Y; Zhang Y; Li B; Xie L; Qin G
BMC Bioinformatics; 2019 May; 20(Suppl 7):195. PubMed ID: 31074374
[TBL] [Abstract][Full Text] [Related]
24. Molecular Pathways: At the Crossroads of Cancer Epigenetics and Immunotherapy.
Maio M; Covre A; Fratta E; Di Giacomo AM; Taverna P; Natali PG; Coral S; Sigalotti L
Clin Cancer Res; 2015 Sep; 21(18):4040-7. PubMed ID: 26374074
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic profiling in CD4+ and CD8+ T cells from Graves' disease patients reveals changes in genes associated with T cell receptor signaling.
Limbach M; Saare M; Tserel L; Kisand K; Eglit T; Sauer S; Axelsson T; Syvänen AC; Metspalu A; Milani L; Peterson P
J Autoimmun; 2016 Feb; 67():46-56. PubMed ID: 26459776
[TBL] [Abstract][Full Text] [Related]
26. Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma.
Dai W; Cheung AK; Ko JM; Cheng Y; Zheng H; Ngan RK; Ng WT; Lee AW; Yau CC; Lee VH; Lung ML
Cancer Med; 2015 Jul; 4(7):1079-90. PubMed ID: 25924914
[TBL] [Abstract][Full Text] [Related]
27. Regulation of AURKC expression by CpG island methylation in human cancer cells.
Fujii S; Srivastava V; Hegde A; Kondo Y; Shen L; Hoshino K; Gonzalez Y; Wang J; Sasai K; Ma X; Katayama H; Estecio MR; Hamilton SR; Wistuba I; Issa JP; Sen S
Tumour Biol; 2015 Sep; 36(10):8147-58. PubMed ID: 25990457
[TBL] [Abstract][Full Text] [Related]
28. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX
J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic and Genetic Regulation of PDCD1 Gene in Cancer Immunology.
Mishra A; Verma M
Methods Mol Biol; 2018; 1856():247-254. PubMed ID: 30178256
[TBL] [Abstract][Full Text] [Related]
30. Germline genetic polymorphisms influence tumor gene expression and immune cell infiltration.
Lim YW; Chen-Harris H; Mayba O; Lianoglou S; Wuster A; Bhangale T; Khan Z; Mariathasan S; Daemen A; Reeder J; Haverty PM; Forrest WF; Brauer M; Mellman I; Albert ML
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11701-E11710. PubMed ID: 30463956
[TBL] [Abstract][Full Text] [Related]
31. Examination of Epigenetic and other Molecular Factors Associated with mda-9/Syntenin Dysregulation in Cancer Through Integrated Analyses of Public Genomic Datasets.
Bacolod MD; Das SK; Sokhi UK; Bradley S; Fenstermacher DA; Pellecchia M; Emdad L; Sarkar D; Fisher PB
Adv Cancer Res; 2015; 127():49-121. PubMed ID: 26093898
[TBL] [Abstract][Full Text] [Related]
32. Glyco-genes change expression in cancer through aberrant methylation.
Vojta A; Samaržija I; Bočkor L; Zoldoš V
Biochim Biophys Acta; 2016 Aug; 1860(8):1776-85. PubMed ID: 26794090
[TBL] [Abstract][Full Text] [Related]
33. A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes.
Youn A; Kim KI; Rabadan R; Tycko B; Shen Y; Wang S
BMC Med Genomics; 2018 Nov; 11(1):98. PubMed ID: 30400878
[TBL] [Abstract][Full Text] [Related]
34. Gene landscape and correlation between B-cell infiltration and programmed death ligand 1 expression in lung adenocarcinoma patients from The Cancer Genome Atlas data set.
Ho KH; Chang CJ; Huang TW; Shih CM; Liu AJ; Chen PH; Cheng KT; Chen KC
PLoS One; 2018; 13(12):e0208459. PubMed ID: 30521597
[TBL] [Abstract][Full Text] [Related]
35. In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma.
Guo X; Xu Y; Zhao Z
Mol Cancer; 2015 Mar; 14():60. PubMed ID: 25890285
[TBL] [Abstract][Full Text] [Related]
36. Pan-cancer analysis reveals an immunological role and prognostic potential of PXN in human cancer.
Chen Y; Zhao H; Xiao Y; Shen P; Tan L; Zhang S; Liu Q; Gao Z; Zhao J; Zhao Y; Guo Y; Feng Y
Aging (Albany NY); 2021 Jun; 13(12):16248-16266. PubMed ID: 34135128
[TBL] [Abstract][Full Text] [Related]
37. Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types.
Iglesia MD; Parker JS; Hoadley KA; Serody JS; Perou CM; Vincent BG
J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27335052
[TBL] [Abstract][Full Text] [Related]
38. A Human Pan-Cancer System Analysis of Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 3 (PLOD3).
Gong S; Duan Y; Wu C; Osterhoff G; Schopow N; Kallendrusch S
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576068
[TBL] [Abstract][Full Text] [Related]
39. DNA methylation profiles in precancerous tissue and cancers: carcinogenetic risk estimation and prognostication based on DNA methylation status.
Arai E; Kanai Y
Epigenomics; 2010 Jun; 2(3):467-81. PubMed ID: 22121905
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers.
Ward AK; Mellor P; Smith SE; Kendall S; Just NA; Vizeacoumar FS; Sarker S; Phillips Z; Alvi R; Saxena A; Vizeacoumar FJ; Carlsen SA; Anderson DH
Breast Cancer Res; 2016 Jan; 18(1):12. PubMed ID: 26810754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
